Yun Jung Min, Hur Na Yeon, Kim Kyeong Han
College of Korean Medicine, Woosuk University, Jeonju, Republic of Korea.
Department of Preventive Medicine, College of Korean Medicine, Woosuk University, Jeonju, Republic of Korea.
J Pharmacopuncture. 2020 Dec 31;23(4):262-272. doi: 10.3831/KPI.2020.23.4.262.
Whiplash injury is one of the major diseases in recent times because of increasing traffic accidents. This review aims to analyze the overall trend of studies on pharmacopuncture for whiplash injury after traffic accidents.
We searched through 4 Korean electronic databases from 2001 up to October 2020 for relevant clinical studies for whiplash injury after traffic accidents, regardless of the patients' age, gender, or race. We included studies that had an intervention group receiving pharmacopuncture therapy with or without other additional treatments, and also included studies that had a control group receiving sham treatment or active treatment such as physical therapy and herbal medication. For the clinical outcomes, we did not place any restrictions on evaluation scales if they are objective metrics.
We included 6 randomized controlled trials (RCTs) and 10 non-randomized controlled trials (nRCTs). 10 nRCTs were divided into 4 categories that were case-control studies, case series, case report, and retrospective observational study. In RCTs, Hwangryun-haedoktang () pharmacopuncture was the most frequently used. In nRCTs, Jungsong-ouhyul () pharmacopuncture, and bee venom pharmacopuncture were the most frequently used. As target points of Hwangryun-haedoktang pharmacopuncture, Ashi-points, Jianjing (GB21), and Fengchi (GB20) were the most frequently used. As target points of Jungsong-ouhyul pharmacopuncture, Ashi-points were the most frequently used. And as target points of Bee venom pharmacopuncture, Fengchi (GB20) was the most frequently used.
Hwangryun-haedoktang pharmacopuncture, bee venom pharmacopuncture, and Jungsong-ouhyul pharmacopuncture were mainly used for whiplash injury, and their usual target points were Jianjing (GB21), Fengchi (GB20), and Ashi-points. However, a high level of evidence should be conducted through studies with systematic methodology in the future.
由于交通事故的增加,挥鞭样损伤是近年来的主要疾病之一。本综述旨在分析交通事故后挥鞭样损伤的药针疗法研究的总体趋势。
我们检索了4个韩国电子数据库,时间跨度从2001年至2020年10月,以查找交通事故后挥鞭样损伤的相关临床研究,不考虑患者的年龄、性别或种族。我们纳入了干预组接受药针疗法(有无其他额外治疗)的研究,也纳入了对照组接受假治疗或积极治疗(如物理治疗和草药治疗)的研究。对于临床结局,如果是客观指标,我们对评估量表不设任何限制。
我们纳入了6项随机对照试验(RCT)和10项非随机对照试验(nRCT)。10项nRCT分为4类,即病例对照研究、病例系列、病例报告和回顾性观察研究。在RCT中,黄连解毒汤药针疗法使用最为频繁。在nRCT中,定神安魂汤药针疗法和蜂毒药针疗法使用最为频繁。作为黄连解毒汤药针疗法的靶点,阿是穴、肩井(GB21)和风池(GB20)使用最为频繁。作为定神安魂汤药针疗法的靶点,阿是穴使用最为频繁。而作为蜂毒药针疗法的靶点,风池(GB20)使用最为频繁。
黄连解毒汤药针疗法、蜂毒药针疗法和定神安魂汤药针疗法主要用于治疗挥鞭样损伤,其常用靶点为肩井(GB21)、风池(GB20)和阿是穴。然而,未来应通过系统方法的研究来获得更高水平的证据。